Skip to main content
. Author manuscript; available in PMC: 2024 Mar 20.
Published in final edited form as: Nat Med. 2022 Jun 23;28(8):1581–1589. doi: 10.1038/s41591-022-01856-6

Extended Data Fig. 6 |. Oncoprint for Patients Receiving MTT.

Extended Data Fig. 6 |

Tumor mutational burden (TMB) and additional alterations in 29 patients who received MTT. Additional alterations are shown if they occurred in >1 case or were potentially targetable. (For the case with high TMB all potentially actionable variants are not shown).